You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Dabur India LimitedFDAMed source confidence · 83%Jun 30, 2026, 1:02 AM UTC · 8d ago
Dabur India Limited — FDA Class II (D-0636-2026)
Case File
Dabur India Limited is recalling 4,374 tubes of a drug due to CGMP (Current Good Manufacturing Practice) deviations. The recall is classified as a Class II recall. The action affects products distributed in the U.S.
•Dabur India Limited is recalling 4,374 tubes of a drug.
•The recall is due to CGMP deviations.
•This is classified as a Class II recall.
•Consumers should check their medicine cabinets.
•Recalls like this can lead to increased regulatory scrutiny.
Why This Matters
Consumers who purchased the recalled drug should stop using it immediately. The recall affects 4,374 tubes, indicating a significant potential safety concern.